Abstract: According to one embodiment, a semiconductor device includes a silicon carbide member, a first member, a first layer, and a second layer. The silicon carbide member includes a first region. The first member includes silicon and oxygen. The first layer is provided between the first region and the first member. The first layer includes a bond between silicon and nitrogen. The second layer is provided between the first layer and the first member. The second layer includes a bond between silicon and oxygen and a bond between silicon and nitrogen.

Abstract: An integrated circuit according to one or more embodiments may include a terminal to which an impedance element and a power supply having a predetermined potential can be connected. The integrated circuit may be configured to change a potential of one of electrodes of the impedance element connected to the terminal, detect a change in electrical characteristics of the terminal based on characteristics of the impedance element when the potential of the one electrode of the impedance element is changed, to determine a setting condition among a plurality of setting conditions that are used for an operation of the integrated circuit, store the setting condition in a storage, and use the setting condition stored in the storage for the operation of the integrated circuit.

Abstract: An integrated circuit according to one or more embodiments may include a terminal to which an impedance element and a power supply having a predetermined potential can be connected. The integrated circuit may be configured to change a potential of one of electrodes of the impedance element connected to the terminal, detect a change in electrical characteristics of the terminal based on characteristics of the impedance element when the potential of the one electrode of the impedance element is changed, to determine a setting condition among a plurality of setting conditions that are used for an operation of the integrated circuit, store the setting condition in a storage, and use the setting condition stored in the storage for the operation of the integrated circuit.

Abstract: Provided is a CVT ring member having a nitrided layer on a surface thereof. The CVT ring member includes a chemical composition containing, by mass, C: 0.43 to 0.70%, Si: 2.50% or less, Mn: 1.00% or less, Cr: 1.50 to 4.00%, Mo: 0.50 to 3.00% and V: 1.00% or less while satisfying a relation of Formula 1: 159×C(%)+91×Si(%)+68×Cr(%)+198×Mo (%)+646?1,000, and the balance being Fe and unavoidable impurities. The ring member has a tensile strength of 1,700 MPa or more. The nitrided layer has a surface hardness of HV800 to HV950.

Abstract: Disclosed is an antibody against a secreted form of GPC3 capable of detecting a secreted form of glypican 3 (GPC3) in a test sample. It is possible to determine whether a subject suffers from cancer, in particular hepatoma. Also disclosed is an antibody against GPC as well as a cell disrupting agent and an anti-cancer agent comprising the same, which can disrupt cells, in particular cancer cells.

Abstract: [Problem] The purpose of the present invention is to provide: a pentasil-type zeolite that combines a higher BET specific surface area and a higher acid amount than previously; and a method for manufacturing said pentasil-type zeolite. [Solution] A pentasil-type zeolite characterized in that the BET specific surface area thereof is 450 m2/g or more, and furthermore the acid amount thereof, measured by the ammonia-TPD method, is 0.38 mmol/g or more. This pentasil-type zeolite can be obtained by a manufacturing method which has a crystallization step for crystallizing a mixture containing tetrabutylphosphonium cations, a silica source, an alumina source, an alkali metal source, and water, and which is characterized in that the molar ratio of the alkali metal relative to the silica in the mixture is greater than 0.04 and less than 0.10.

Abstract: Disclosed is an antibody against a secreted form of GPC3 capable of detecting a secreted form of glypican 3 (GPC3) in a test sample. It is possible to determine whether a subject suffers from cancer, in particular hepatoma. Also disclosed is an antibody against GPC as well as a cell disrupting agent and an anti-cancer agent comprising the same, which can disrupt cells, in particular cancer cells.

Abstract: A method for diagnosing cancer comprising detecting ROBO1 protein is disclosed. In addition, a method for treating a disease caused by abnormal cell growth comprising administrating an antibody that binds to ROBO1, as well as a pharmaceutical composition, a cell growth inhibitor and an anticancer agent comprising an antibody that binds to ROBO1 as an active ingredient are disclosed. Further, a method for inducing cell damages in a ROBO1 expressing cell and a method for inhibiting the growth of a ROBO1 expressing cell by bringing a ROBO1 expressing cell into contact with an antibody that binds to ROBO1, are disclosed. Furthermore, a method for monitoring progression of hepatitis by detecting ROBO1 protein is disclosed.

Abstract: An image forming apparatus for forming images to a medium, includes an apparatus housing; a temperature detection unit for detecting a temperature of a surrounding of the apparatus housing; a dehumidifying unit for dehumidifying an interior surrounded by the apparatus housing; and a dehumidifying decision unit for operating the dehumidifying unit based on a change of the detected temperature at the temperature detection unit, to certainly remove dew condensation

Abstract: Provided is a method for diagnosing cancer by detecting a novel cancer marker. Cancer can be diagnosed by detecting soluble glypican 3 in a test sample.

Abstract: Provided is a CVT ring member having a nitrided layer on a surface thereof. The CVT ring member includes a chemical composition containing, by mass, C: 0.43 to 0.70%, Si: 2.50% or less, Mn: 1.00% or less, Cr: 1.50 to 4.00%, Mo: 0.50 to 3.00% and V: 1.00% or less while satisfying a relation of Formula 1: 159×C(%)+91×Si(%)+68×Cr(%)+198×Mo (%)+646?1,000, and the balance being Fe and unavoidable impurities. The ring member has a tensile strength of 1,700 MPa or more. The nitrided layer has a surface hardness of HV800 to HV950.

Abstract: Disclosed are a protein encoded by a gene having a nucleotide sequence represented by any of SEQ ID NOs: 1 to 65 or a fragment thereof, an antibody recognizing the protein or antigen-binding fragment thereof, and a polynucleotide having a sequence comprising at least 12 consecutive nucleotides of a nucleotide sequence represented by any of SEQ ID NOs: 1 to 65 or a nucleotide sequence complementary thereto. The gene and the protein of the invention is useful for diagnosing and treating cancer.

Abstract: [Problem] The purpose of the present invention is to provide: a pentasil-type zeolite that combines a higher BET specific surface area and a higher acid amount than previously; and a method for manufacturing said pentasil-type zeolite. [Solution] A pentasil-type zeolite characterized in that the BET specific surface area thereof is 450 m2/g or more, and furthermore the acid amount thereof, measured by the ammonia-TPD method, is 0.38 mmol/g or more. This pentasil-type zeolite can be obtained by a manufacturing method which has a crystallization step for crystallizing a mixture containing tetrabutylphosphonium cations, a silica source, an alumina source, an alkali metal source, and water, and which is characterized in that the molar ratio of the alkali metal relative to the silica in the mixture is greater than 0.04 and less than 0.10.

Abstract: Disclosed are a protein encoded by a gene having a nucleotide sequence represented by any of SEQ ID NOs: 1 to 65 or a fragment thereof, an antibody recognizing the protein or antigen-binding fragment thereof, and a polynucleotide having a sequence comprising at least 12 consecutive nucleotides of a nucleotide sequence represented by any of SEQ ID NOs: 1 to 65 or a nucleotide sequence complementary thereto. The gene and the protein of the invention is useful for diagnosing and treating cancer.

Abstract: A method for diagnosing cancer comprising detecting ROBO1 protein is disclosed. In addition, a method for treating a disease caused by abnormal cell growth comprising administrating an antibody that binds to ROBO1, as well as a pharmaceutical composition, a cell growth inhibitor and an anticancer agent comprising an antibody that binds to ROBO1 as an active ingredient are disclosed. Further, a method for inducing cell damages in a ROBO1 expressing cell and a method for inhibiting the growth of a ROBO1 expressing cell by bringing a ROBO1 expressing cell into contact with an antibody that binds to ROBO1, are disclosed. Furthermore, a method for monitoring progression of hepatitis by detecting ROBO1 protein is disclosed.

Abstract: An image formation apparatus includes: an interface unit that receives data; an image formation unit that forms an image on a medium based on the received data; a main controller that controls the interface unit and the image formation unit; a power supply unit that supplies power from an external power source into the image formation apparatus; and a power source management unit that controls the power supply unit. When the power supply from the external power source is stopped in a power save mode and then is resumed, the power supply unit supplies no power to the interface unit and the main controller but supplies power to the power source management unit. When the power supply from the external power source is stopped in a normal operational mode and then is resumed, the power supply unit supplies power to the power source management unit, the interface unit, and the main controller.

Abstract: Provided is a method for diagnosing cancer by detecting a novel cancer marker. Cancer can be diagnosed by detecting soluble glypican 3 in a test sample.

Abstract: A method for diagnosing cancer comprising detecting ROBO1 protein is disclosed. In addition, a method for treating a disease caused by abnormal cell growth comprising administrating an antibody that binds to ROBO1, as well as a pharmaceutical composition, a cell growth inhibitor and an anticancer agent comprising an antibody that binds to ROBO1 as an active ingredient are disclosed. Further, a method for inducing cell damages in a ROBO1 expressing cell and a method for inhibiting the growth of a ROBO1 expressing cell by bringing a ROBO1 expressing cell into contact with an antibody that binds to ROBO1, are disclosed. Furthermore, a method for monitoring progression of hepatitis by detecting ROBO1 protein is disclosed.

Abstract: An image forming apparatus includes: an apparatus body settable to any of at least first and second modes; a replacement part detachably attachable to the apparatus body; a first storage provided in the apparatus body and configured to store ID information for at least a selected one of the first and second modes; a second storage provided in the replacement part and configured to store ID information of the replacement part; and a determination section configured to compare the ID information of the apparatus body stored in the first storage with the ID information of the replacement part stored in the second storage to determine whether to permit use of the replacement part, wherein the second storage of the replacement part shipped with the image forming apparatus stores at least first ID information for the first mode and second ID information for the second mode.

Abstract: A subject for the invention is to provide a highly heat-resistant SCR catalyst which has an NOx reduction percentage of 40% or higher at 200° C. after a hydrothermal durability treatment. The invention relates to use of ?-type zeolite which has an SiO2/Al2O3 molar ratio of 20 or higher but less than 30 and a crystallite diameter before a hydrothermal durability treatment of 20 nm or larger, shows a change in crystallite through the hydrothermal durability treatment of less than 10%, and has a fluorine content lower than 0.1%. The ?-type zeolite can be crystallized from a liquid reaction mixture containing a secondary and/or a tertiary alkylamine having 5 or more carbon atoms.